Synopsys (SNPS) Stock Forecast, Price & News

11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Synopsys in the last twelve months. There are currently 1 hold rating and 10 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" SNPS shares.
View SNPS analyst ratings or view top-rated stocks.

11 Wall Street research analysts have issued 12 month price objectives for Synopsys' stock. Their SNPS share price forecasts range from $400.00 to $515.00. On average, they predict the company's share price to reach $462.50 in the next twelve months. This suggests a possible upside of 3.5% from the stock's current price.
View analysts price targets for SNPS or view top-rated stocks among Wall Street analysts.

Synopsys' stock was trading at $319.29 at the beginning of the year. Since then, SNPS shares have increased by 40.0% and is now trading at $446.85.
View the best growth stocks for 2023 here.

Synopsys saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 1,210,000 shares, an increase of 25.1% from the August 15th total of 966,900 shares. Based on an average daily trading volume, of 865,700 shares, the short-interest ratio is currently 1.4 days. Currently, 0.8% of the company's stock are short sold.
View Synopsys' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 29th 2023.
View our SNPS earnings forecast.

Synopsys, Inc. (NASDAQ:SNPS) announced its quarterly earnings data on Wednesday, August, 16th. The semiconductor company reported $2.88 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.74 by $0.14. The semiconductor company had revenue of $1.49 billion for the quarter, compared to the consensus estimate of $1.48 billion. Synopsys had a net margin of 18.71% and a trailing twelve-month return on equity of 18.01%. Synopsys's quarterly revenue was up 19.2% on a year-over-year basis. During the same period in the previous year, the business earned $1.43 earnings per share.
Read the conference call transcript.

ETFs with the largest weight of Synopsys (NASDAQ:SNPS) stock in their portfolio include Invesco Dynamic Software ETF (PSJ), ProShares Nasdaq-100 Dorsey Wright Momentum ETF (QQQA), Mohr Growth ETF (MOHR), Franklin Intelligent Machines ETF (IQM), BlackRock Future Tech ETF (BTEK), Invesco Focused Discovery Growth ETF (IVDG), Columbia Seligman Semiconductor and Technology ETF (SEMI) and VanEck Semiconductor ETF (SMH).

Synopsys declared that its board has authorized a stock buyback program on Thursday, September 1st 2022, which authorizes the company to repurchase $1,500,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to buy up to 2.9% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company's board believes its stock is undervalued.

Synopsys updated its FY23 earnings guidance on Wednesday, August, 16th. The company provided EPS guidance of $11.04-11.09 for the period, compared to the consensus estimate of $10.82. The company issued revenue guidance of $5.81-5.84 billion, compared to the consensus revenue estimate of $5.82 billion.

1,170 employees have rated Synopsys Chief Executive Officer Dr. Aart J. de Geus and Dr. Chi-Foon Chan on Glassdoor.com. Dr. Aart J. de Geus and Dr. Chi-Foon Chan has an approval rating of 95% among the company's employees. This puts Dr. Aart J. de Geus and Dr. Chi-Foon Chan in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Synopsys investors own include NVIDIA (NVDA), PayPal (PYPL), Alibaba Group (BABA), Block (SQ), Salesforce (CRM), Advanced Micro Devices (AMD), Adobe (ADBE), Tesla (TSLA), Netflix (NFLX) and Micron Technology (MU).

Synopsys trades on the NASDAQ under the ticker symbol "SNPS."

Synopsys' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Bank Julius Baer & Co. Ltd Zurich (27.41%), BlackRock Inc. (7.72%), State Street Corp (4.39%), Capital World Investors (4.07%), Franklin Resources Inc. (2.35%) and Geode Capital Management LLC (1.91%). Insiders that own company stock include Chi-Foon Chan, Chrysostomos L Nikias, Geus Aart De, Janice Chaffin, John F Runkel Jr, Joseph W Logan, Mercedes Johnson, Richard S Mahoney, Roy Vallee, Sassine Ghazi, Steven Walske, Sudhindra Kankanwadi and Trac Pham.
View institutional ownership trends.

Shares of SNPS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SNPS stock can currently be purchased for approximately $446.85.

Synopsys (NASDAQ:SNPS) has a market capitalization of $67.97 billion and generates $5.08 billion in revenue each year. The semiconductor company earns $984.59 million in net income (profit) each year or $6.67 on an earnings per share basis.

The company employs 19,000 workers across the globe.

Synopsys' mailing address is 690 EAST MIDDLEFIELD ROAD, MOUNTAIN VIEW CA, 94043. The official website for the company is www.synopsys.com. The semiconductor company can be reached via phone at (650) 584-5000, via email at synopsys-ir@synopsys.com, or via fax at 650-965-8637.